PT-141 for sexual dysfunction: what TikTok gets wrong

What did @meranda.ratliff actually say?

Not much, honestly. The entire video is a single question: "Just curious if you get the peptide PT one more one. Where do you get it from?" That's it. There's no claim being made about what PT-141 does, no dosing advice, no before-and-after story. It's a sourcing question directed at her audience, likely other users who have experience with the peptide.

PT-141, also known by its chemical name bremelanotide, is a synthetic melanocortin receptor agonist. It was approved by the FDA in 2019 under the brand name Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. So this is not some fringe research compound. There is an FDA-approved version. The question of where people are sourcing it, though, opens a real can of worms, which we'll get into.

Does the science back this up?

There's no scientific claim here to evaluate, but the background science on PT-141 is worth laying out since that's presumably why people are interested in it.

PT-141 works differently from most sexual function treatments. Unlike PDE5 inhibitors such as sildenafil, it doesn't act on the vascular system. It activates melanocortin receptors in the central nervous system, specifically MC3R and MC4R, which influence sexual arousal pathways in the brain. The FDA approval was based on two randomized controlled trials (Portman et al., 2017, Journal of Sexual Medicine) showing statistically significant improvements in satisfying sexual events and reduced distress in women with HSDD. That's a real finding from real trials.

For men, the research is less formal. Early Phase 2 trials (Diamond et al., 2004, Annals of the New York Academy of Sciences) showed promising results for erectile dysfunction and sexual arousal, but no male indication ever reached FDA approval. Most male use today is off-label at best, or sourced through channels outside the pharmacy system at worst.

What did they get wrong (or right)?

There's nothing factually wrong in this video because nothing factual was stated. Asking where people source a peptide is not a medical claim. That said, the implicit framing here is worth flagging.

When someone asks "where do you get it from" on a public platform, the answers that come back in the comments are almost certainly going to point toward gray-market or research chemical suppliers, not licensed compounding pharmacies and definitely not the FDA-approved Vyleesi product. That's a meaningful distinction. Research chemical suppliers are not regulated for purity, concentration, or sterility. A 2021 analysis published in JAMA Internal Medicine (Cohen et al.) found significant labeling and concentration inaccuracies across compounds sold as peptides through unregulated online vendors.

So the video itself doesn't spread misinformation. But it functions as a prompt for a conversation that frequently produces unreliable sourcing advice. That's not the creator's fault in a direct sense, but it's the real-world consequence of the format.

What should you actually know?

If you're interested in PT-141 specifically, the sourcing question is genuinely the most important one, and the answer matters more than most people realize.

The FDA-approved version, Vyleesi (bremelanotide), is available by prescription through licensed pharmacies for women with HSDD. Compounded versions of bremelanotide are available through some telehealth platforms, but compounded drugs are not FDA-approved and are not equivalent to brand-name products in terms of regulatory oversight. Never assume they are interchangeable.

Peptides sourced from research chemical vendors exist in a completely different regulatory universe. They are sold as "not for human use" to avoid drug regulations, but they are widely purchased for exactly that purpose. The risks include unknown purity, incorrect concentration, bacterial contamination, and zero recourse if something goes wrong.

• Common side effects from clinical trials include nausea, flushing, and transient blood pressure changes (Kingsberg et al., 2019, Obstetrics and Gynecology).
• Those side effects were documented in controlled settings with verified compounds. With unverified sourcing, you're adding unknown variables on top of known risks.
• If you're curious about PT-141, the conversation should start with a licensed provider, not a TikTok comment section.